120 related articles for article (PubMed ID: 32327298)
21. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
[No Abstract] [Full Text] [Related]
22. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
23. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
24. Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Marcus PM; Ogden SL; Gren LH; Childs JC; Pretzel SM; Lamerato LE; Walsh K; Rozjabek HM; Mabie J; Thomas B; Riley T
Prev Med; 2014 Oct; 67():82-8. PubMed ID: 25038532
[TBL] [Abstract][Full Text] [Related]
25. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
26. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.
Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC
J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432
[TBL] [Abstract][Full Text] [Related]
28. The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC).
Pakarainen T; Nevalainen J; Talala K; Taari K; Raitanen J; Kujala P; Stenman UH; Tammela TLJ; Auvinen A
Clin Cancer Res; 2019 Jan; 25(2):839-843. PubMed ID: 30322875
[TBL] [Abstract][Full Text] [Related]
29. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
[TBL] [Abstract][Full Text] [Related]
30. Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening.
Liss MA; Chen H; Hemal S; Krane S; Kane CJ; Xu J; Kader AK
J Urol; 2015 Jan; 193(1):75-9. PubMed ID: 25066872
[TBL] [Abstract][Full Text] [Related]
31. Neighbourhoods matter too: the association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008.
Meijer M; Bloomfield K; Engholm G
J Epidemiol Community Health; 2013 Jan; 67(1):6-13. PubMed ID: 22826293
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Prostatectomy versus Radiation Therapy in the Management of Clinically Localized Prostate Cancer Patients Within the PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Apr; 17(2):e329-e338. PubMed ID: 30704795
[TBL] [Abstract][Full Text] [Related]
33. Prediagnostic BMI and thyroid cancer incidence in the PLCO trial.
Abdel-Rahman O
Future Oncol; 2019 Oct; 15(30):3451-3456. PubMed ID: 31646903
[No Abstract] [Full Text] [Related]
34. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
[TBL] [Abstract][Full Text] [Related]
35. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
de Koning HJ; Auvinen A; Berenguer Sanchez A; Calais da Silva F; Ciatto S; Denis L; Gohagan JK; Hakama M; Hugosson J; Kranse R; Nelen V; Prorok PC; Schröder FH; ;
Int J Cancer; 2002 Jan; 97(2):237-44. PubMed ID: 11774270
[TBL] [Abstract][Full Text] [Related]
36. Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial.
Abdel-Rahman O
Expert Rev Respir Med; 2019 Oct; 13(10):1029-1035. PubMed ID: 31414914
[No Abstract] [Full Text] [Related]
37. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
38. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
39. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
40. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
